French venture capital firm Five Seasons has held a €180m final closing for Fund II, three years after closing its debut fund. The post Five Seasons holds €180m final close for Fund II, expects 20x
Global buyout major KKR has tapped its fourth Asian fund to buy into Australian customer experience and business process outsourcing company Probe. The post KKR taps fourth Asian fund to buy into Australian CX, BPO
European buyout house EQT has hired Tetsuro Onitsuka as head of EQT private equity and Masahiko Kato as head of EQT Infrastructure in the newly-established Japan office. The pair will build the team with both local and
Advent France Biotechnology has held an €86m first close for its second fund, already surpassing the size of its debut vehicle in the strategy. The post Advent France Biotechnology holds €86m first close for Fund
HIG has bought into UK generic and branded pharmaceutical supplier Aspire Pharma. The post HIG buys into niche pharmaceutical products supplier Aspire Pharma first appeared on AltAssets Private Equity News.
Italian life sciences investor Panakès Partners has hired Rob Woodman as partner to lead the firm’s newly created biotech investment team. The post Italy’s Panakès Partners hires industry veteran Rob Woodman to lead new biotech
Global buyout giant Apollo has promoted senior partner Matt Michelini to head of Asia-Pacific, to oversee the firm’s investment and non-investment activities and external relationships in the region. He will continue in his role as
Ara Partners, a specialist buyout firm focuses on industrial decarbonization investments has closed Ara Fund II with $1.1bn of investments, almost triple the size of its $400m predecessor Fund I. The oversubscribed fund is also
Specialist investor Blue Bear has closed its second venture capital fund on its $150m hard cap. AIMS Imprint of Goldman Sachs Asset Management, Rockefeller Brothers Fund, ZOMA Capital and McKnight Foundation took part in the
Specialist buyout house WM Partners, which focuses on the health and wellness sector, has collected $550m for its second fund, swooping past both its original $400m target and the size of its debut vehicle. The
Infrastructure buyout house Cube IM has held the first close of its third flagship fund on €1bn, reaching 65% of its €1.5bn target. The vehicle is already the firm’s biggest flagship fund to date. The
UK mid-market buyout house Graphite Capital has promoted three senior partners, one partner and an investment manager and hired a trio of investment executives to "enhance its investment capability". The post Graphite makes strings of
Biotech investor Jeito Capital has held a €534m final close for its debut fund to mark the largest life science fundraise in Europe to date. The post Jeito Capital closes the largest life sciences fund in
Asset manager Unigestion's private equity unit has bought into European home care services provider Home Instead. The post Unigestion buys into European elderly home care services provider Home Instead to capture market growth first appeared
Microcap investor Shore Capital Partners has hired Brad Morehead as partner and head of the firm’s recently-closed business services fund. The post Shore Capital hires Morehead as partner to lead newly-closed business services fund first
Specialist investor Lever VC has held an $80m final close for its inaugural fund to back early-stage plant-based and cultivated meat and dairy companies. The firm said it is already actively speaking with investors to
Micro market-focused buyout house Evolution Capital Partners has hired Jessica Leonard as partner. The post Evolution Capital hires Jessica Leonard as new partner first appeared on AltAssets Private Equity News.
UK private equity firm Bridgepoint Development has tapped its fourth flagship fund to acquire supply chain risk management company Achilles. The post Bridgepoint adds Achilles to Fund IV portfolio amid global supply chain pressure first
An estimated 25% of global drug production is in the hands of little-known players CDMOs, making them indispensable for industry, global healthcare systems and patients - not least during Covid. Navigating this terrain is tricky,
The coronavirus crisis has raged across the globe for months now - but some businesses were far quicker to adapt to the growing disaster than others. Private debt investment specialist CVI explains how some of
